Incompatible living donor kidney transplant recipients (ILDKT) have pre-existing donor-specific antibody (DSA) that, despite desensitization, may persist or reappear with resulting consequences, including delayed graft function (DGF) and acute rejection (AR). To quantify the risk of DGF and AR in ILDKT and downstream effects, we compared 1,406 ILDKT to 17,542 compatible LDKT (CLDKT) recipients using a 25-center cohort with novel SRTR linkage. We characterized DSA strength as positive-Luminex, negative-flow crossmatch (PLNF); positive-flow, negative-cytotoxic crossmatch (PFNC); or positive-cytotoxic crossmatch (PCC). DGF occurred in 3.1% of CLDKT, 3.5% of PLNF, 5.7% of PFNC, and 7.6% of PCC recipients, which translated to higher DGF for PCC recipients (aOR= 1.68 . ). However, the impact of DGF on mortality and DCGF risk was no higher for ILDKT than CLDKT (p interaction>0.1). AR developed in 8.4% of CLDKT, 18.2% of PLNF, 21.3% of PFNC, and 21.7% of PCC recipients, which translated to higher AR (aOR PLNF= 2.09 ;PFNC= 2.40 ;PCC= 2.24 ). Although the impact of AR on mortality was no higher for ILDKT than CLDKT (p interaction=0.1), its impact on DCGF risk was less consequential for ILDKT (aHR= 1.62 ) than CLDKT (aHR= 2.29 ) (p interaction=0.004). Providers should consider these risks during pre-operative counselling, and strategies to mitigate them should be considered.This article is protected by copyright. All rights reserved.
About The Expert
Jennifer D Motter
Kyle R Jackson
Jane J Long
Madeleine M Waldram
Babak J Orandi
Robert A Montgomery
Mark D Stegall
Stanley C Jordan
Enrico Benedetti
Ty B Dunn
Lloyd E Ratner
Sandip Kapur
Ronald P Pelletier
John P Roberts
Marc L Melcher
Pooja Singh
Debra L Sudan
Marc P Posner
Jose M El-Amm
Ron Shapiro
Matthew Cooper
Jennifer E Verbesey
George S Lipkowitz
Michael A Rees
Christopher L Marsh
Bashir R Sankari
David A Gerber
Jason R Wellen
Adel Bozorgzadeh
A Osama Gaber
Eliot C Heher
Francis L Weng
Arjang Djamali
J Harold Helderman
Beatrice P Concepcion
Kenneth L Brayman
Jose Oberholzer
Tomasz Kozlowski
Karina Covarrubias
Allan B Massie
Dorry L Segev
Jacqueline M Garonzik-Wang
References
PubMed